These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3346203)

  • 1. The dexamethasone suppression test in bulimia: nonsuppression associated with depression and suboptimal weight.
    Perez EL; Blouin J; Blouin A
    J Clin Psychiatry; 1988 Mar; 49(3):94-6. PubMed ID: 3346203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two diagnostic correlates of dexamethasone nonsuppression in normal weight bulimia.
    Blinder BJ; Chaitin BF; Hagman J
    Hillside J Clin Psychiatry; 1987; 9(2):211-6. PubMed ID: 3428880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in patients with bulimia.
    Mitchell JE; Pyle RL; Hatsukami D; Boutacoff LI
    J Clin Psychiatry; 1984 Dec; 45(12):508-11. PubMed ID: 6594328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is bulimia associated with borderline personality disorder? A controlled study.
    Pope HG; Frankenburg FR; Hudson JI; Jonas JM; Yurgelun-Todd D
    J Clin Psychiatry; 1987 May; 48(5):181-4. PubMed ID: 3571171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test in bulimia before and after successful treatment with desipramine.
    Hughes PL; Wells LA; Cunningham CJ
    J Clin Psychiatry; 1986 Oct; 47(10):515-7. PubMed ID: 3759916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppression test in primary depression: significance of family history and psychosis.
    Rudorfer MV; Hwu HG; Clayton PJ
    Biol Psychiatry; 1982 Jan; 17(1):41-8. PubMed ID: 7059638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test: interaction of diagnosis, sex, and age in psychiatric inpatients.
    Nelson WH; Khan A; Orr WW; Tamragouri RN
    Biol Psychiatry; 1984 Sep; 19(9):1293-304. PubMed ID: 6498252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms.
    Reus VI
    Biol Psychiatry; 1982 Mar; 17(3):317-26. PubMed ID: 7082699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between depression and the dexamethasone suppression test following alcohol withdrawal in a psychiatric population.
    Johnson B; Perry JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):343-9. PubMed ID: 3805327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations between clinico-psychiatric findings and the dexamethasone suppression test in depression].
    Rupprecht R; Barocka A; Pichl J
    Psychiatr Prax; 1988 Jul; 15(4):142-5. PubMed ID: 3406225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and the dexamethasone suppression test (DST) in patients with non-specific somatic complaints. Atypical depression and DST.
    Syvälahti E; Hyyppä MT; Salminen JK
    Ann Clin Res; 1985; 17(4):148-51. PubMed ID: 4073803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression, anxiety and the dexamethasone suppression test in hospitalized prepubertal children.
    Livingston R; Martin-Cannici C
    Hillside J Clin Psychiatry; 1987; 9(1):55-63. PubMed ID: 3653843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and anxiety inventories, and the dexamethasone suppression test.
    Sangal R; Correa EI; DePaulo JR
    Biol Psychiatry; 1984 Aug; 19(8):1207-13. PubMed ID: 6498243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obsessive-compulsive disorder, depression, and the dexamethasone suppression test.
    Jenike MA; Baer L; Brotman AW; Goff DC; Minichiello WE; Regan NJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):182-4. PubMed ID: 3597805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortisol responses on the dexamethasone suppression test among women with Bulimia-spectrum eating disorders: associations with clinical symptoms.
    Bruce KR; Steiger H; Israël M; Groleau P; Ng Ying Kin NM; Ouellette AS; Sycz L; Badawi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):241-6. PubMed ID: 22575215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression in depressed elderly outpatients.
    Allen RE; Pitts FN
    J Clin Psychiatry; 1984 Sep; 45(9):397-8. PubMed ID: 6469926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants.
    Saran AS
    J Clin Psychiatry; 1985 Aug; 46(8):335-8. PubMed ID: 4019422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In unipolar depression does the response to the dexamethasone suppression test predict a symptomatic recurrence after clinical cure?].
    Charles G; Schittecatte M; Maes JM; Rush AJ; Wilmotte J
    Acta Psychiatr Belg; 1986; 86(3):249-56. PubMed ID: 3751648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.